<VariationArchive RecordType="classified" VariationID="97157" VariationName="NM_000531.6(OTC):c.29_32del (p.Asn10fs)" VariationType="Deletion" Accession="VCV000097157" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-26" DateCreated="2014-02-20" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="103049" VariationID="97157">
      <GeneList>
        <Gene Symbol="OTC" FullName="ornithine transcarbamylase" GeneID="5009" HGNC_ID="HGNC:8512" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="38327684" stop="38422928" display_start="38327684" display_stop="38422928" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="38211735" stop="38280702" display_start="38211735" display_stop="38280702" Strand="+" />
          </Location>
          <OMIM>300461</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OTC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OTC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000531.6(OTC):c.29_32del (p.Asn10fs)</Name>
      <CanonicalSPDI>NC_000023.11:38352722:AAACAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="38352723" stop="38352726" display_start="38352723" display_stop="38352726" variantLength="4" positionVCF="38352722" referenceAlleleVCF="TAAAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="38211976" stop="38211979" display_start="38211976" display_stop="38211979" variantLength="4" positionVCF="38211975" referenceAlleleVCF="TAAAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>N10fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.38211978_38211981del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.38211978_38211981del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.38352725_38352728del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.38352725_38352728del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008471.1" sequenceAccession="NG_008471" sequenceVersion="1" change="g.5243_5246del">
            <Expression>NG_008471.1:g.5243_5246del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000531.6" sequenceAccession="NM_000531" sequenceVersion="6" change="c.29_32del" MANESelect="true">
            <Expression>NM_000531.6:c.29_32del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000522.3" sequenceAccession="NP_000522" sequenceVersion="3" change="p.Asn10fs">
            <Expression>NP_000522.3:p.Asn10fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_846" sequenceAccession="LRG_846">
            <Expression>LRG_846:g.5243_5246del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_846t1" sequenceAccession="LRG_846t1">
            <Expression>LRG_846t1:c.29_32del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_846p1" sequenceAccession="LRG_846p1" change="p.Asn10fs">
            <Expression>LRG_846p1:p.Asn10fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA224540" DB="ClinGen" />
        <XRef Type="rs" ID="72552297" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000531.6(OTC):c.29_32del (p.Asn10fs) AND not provided" Accession="RCV000083390" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000531.6(OTC):c.29_32del (p.Asn10fs) AND Ornithine carbamoyltransferase deficiency" Accession="RCV002490733" Version="1">
        <ClassifiedConditionList TraitSetID="3053">
          <ClassifiedCondition DB="MedGen" ID="C0268542">Ornithine carbamoyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-02-20" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16786505</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3053" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3120" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO</ElementValue>
                <XRef Type="MIM" ID="311250" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ornithine transcarbamylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ornithine carbamoyltransferase deficiency</ElementValue>
                <XRef ID="Ornithine+transcarbamylase+deficiency/5412" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010703" DB="MONDO" />
                <XRef ID="80908008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OTC deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ornithine Carbamoyltransferase Deficiency Disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OTCD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Ornithine transcarbamylase (OTC) deficiency can occur as a severe neonatal-onset disease in males (but rarely in females) and as a post-neonatal-onset (also known as "late-onset" or partial deficiency) disease in males and females. Males with severe neonatal-onset OTC deficiency are asymptomatic at birth but become symptomatic from hyperammonemia in the first week of life, most often on day two to three of life, and are usually catastrophically ill by the time they come to medical attention. After successful treatment of neonatal hyperammonemic coma these infants can easily become hyperammonemic again despite appropriate treatment; they typically require liver transplant to improve quality of life. Males and heterozygous females with post-neonatal-onset (partial) OTC deficiency can present from infancy to later childhood, adolescence, or adulthood. No matter how mild the disease, a hyperammonemic crisis can be precipitated by stressors and become a life-threatening event at any age and in any situation in life. For all individuals with OTC deficiency, typical neuropsychological complications include developmental delay, learning disabilities, intellectual disability, attention-deficit/hyperactivity disorder, and executive function deficits.</Attribute>
                <XRef ID="NBK154378" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8391" />
                <XRef ID="8391" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24006547</ID>
                <ID Source="BookShelf">NBK154378</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Decreased-Citrulline.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased Citrulline, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Decreased-Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Decreased Citrulline, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/OTC-Deficiency-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Ornithine Transcarbamylase (OTC) deficiency, 2012</CitationText>
              </Citation>
              <XRef ID="664" DB="Orphanet" />
              <XRef ID="C0268542" DB="MedGen" />
              <XRef ID="MONDO:0010703" DB="MONDO" />
              <XRef Type="MIM" ID="311250" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="203279" SubmissionDate="2013-02-14" DateLastUpdated="2014-02-20" DateCreated="2014-02-20">
        <ClinVarSubmissionID localKey="OTC_AAA0000005" />
        <ClinVarAccession Accession="SCV000115476" DateUpdated="2014-02-20" DateCreated="2014-02-20" Type="SCV" Version="1" SubmitterName="GenMed Metabolism Lab" OrgID="500231" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">16786505</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000531.5:c.28_31delAACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="300461" Status="under review" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">Frameshift, Female</Comment>
        <SubmissionNameList>
          <SubmissionName>OTC_Aug2008</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5435164" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000531.6:c.29_32del|OMIM:311250" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002779516" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="clinic" OrgAbbreviation="FLGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000531.6:c.29_32del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="311250" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5435164" TraitType="Disease" MappingType="XRef" MappingValue="311250" MappingRef="OMIM">
        <MedGen CUI="C0268542" Name="Ornithine carbamoyltransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="203279" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

